| Factor Information | |
|---|---|
| Data ID | 242 |
| Factor | extra corporeal membrane oxygenation(ECMO) use with seizures |
| Description | incidence of ECMO in CHD |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | children with CHD of clinical seizure |
| p Value | 0.013 |
| Conclusion | Univariate analyses showed that clinical seizure were more common in patients with higher RACHS (Risk Adjustment for Congenital Heart Surgery scores, delayed sternal closure and ECMO use. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 432 |
| CHD Type | isolated CHD |
| CHD Subtype | DCM/Cortriatriatum/DORV/HLHS/AVC/CoA/TOF/TGA/Shone's Complex |
| Reference | |
|---|---|
| PMID | 30557820 |
| Year | 2019 |
| Title | Epilepsy and seizures in children with congenital heart disease: A prospective study. |
| Sample | ||
|---|---|---|
| Population | children | |
| Source | data | |
| Region | canada, Montreal | |
| Method | univariable logistic analysis | |
| Race | American | |
| Disease History | N/A | |
| Treatment History | cardiac surgery with of without cardiopulmobary bypass | |
| Group | CHD patients with clinical seizure(Treatment) | CHD patients with no clinical seizure(Control) |
| Number | 2 | 2 |
| Age | 5.25 months (0.2-12 months) | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 0.2 | 0.02 |
